Back to UBS Group AG UBS Group AG

MAIAMAIA
Showing 8 of 15 quarters

Position history for UBS Group AGUBS Group AG's holdings in MAIA BIOTECHNOLOGY INC

Yes. Ubs holds 33,435 shares of MAIA (Maia Biotechnology), worth $48,147, as of its Q2 2026 13F filing. It reduced the position by 18,482 shares (-35.6%) from Q1 2026. Ubs has held MAIA since Q4 2025, across 3 quarterly 13F filings.

Current Value

$48,147

Current Shares

33,435

Total Value Change

+$1,262

Total Shares Change

+16,750

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
33,435
-35.6%
$48,1470.0%$1.44
0
2026-Q1
Increased
51,917
+2292.5%
$72,6840.0%$1.51
23
2025-Q4
New
2,170
-
$3,3200.0%$1.33
21
2025-Q3
Exited
0
-100.0%
$00.0%$1.60
0
2025-Q2
Increased
2,120
+606.7%
$3,8160.0%$1.77
15
2025-Q1
New
300
-
$4590.0%$1.62
17
2024-Q4
Exited
0
-100.0%
$00.0%$2.01
0
2024-Q3
New
16,685
-
$46,8850.0%$2.61
31

Other major holders of MAIA: Alyeska Investment Group, L.P., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used